Regulatory FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients pharminent June 2, 2026
Clinical Data REGENXBIO slumps after serious side effects mar Duchenne gene therapy results pharminent May 14, 2026
Regulatory With new data, Regenxbio to seek FDA approval of Duchenne gene therapy pharminent May 14, 2026
Pipeline Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases pharminent April 27, 2026
Gene Therapy Gene therapy leaders aim to help more Baby KJs with novel regulatory models pharminent April 27, 2026
Policy / Pricing Regeneron cuts White House pricing deal, offers new gene therapy for free pharminent April 24, 2026
Pipeline Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine pharminent April 21, 2026
M&A / Deals Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout pharminent April 20, 2026
M&A / Deals Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal pharminent April 20, 2026
Regulatory FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development pharminent April 14, 2026
Other 219: An Interview With Dr. Natalie Truba on the Psychological Aspects of Gene Therapy pharminent April 7, 2026
